• Those Who Purchased Basilea Pharmaceutica (VTX:BSLN) Shares Five Years Ago Have A 45% Loss To Show For It

    It is a pleasure to report that the Basilea Pharmaceutica AG (VTX:BSLN) is up 43% in the last quarter. But that...


  • JPMorgan Says Short U.S. 30-Year Bond on Excess Haven Demand

    (Bloomberg) -- JPMorgan Chase & Co. strategists are betting that the surge in demand for Treasuries thanks to fears about the deadly coronavirus will prove short-lived, sticking with a call to sell longer-dated bonds.Among the Wall Street bank’s other takeaways from their latest market-outlook reports: the outbreak of the disease is a “clear negative” for emerging Asian currencies, while for stocks it could be a buying opportunity if historical parallels hold.“This is the latest risk of a series that have driven U.S. Treasury yields far below what fundamentals indicate,” strategists including Matthew Jozoff wrote in a note Friday. “We don’t intend to be dismissive of the coronavirus, as it is a serious concern both in human and economic turns,” they wrote, while flagging that JPMorgan analysis notes a trend toward reduced mortality in health epidemics over time.Geopolitical tensions stemming from Iran spurred a rally in Treasuries earlier this month, before the coronavirus emerged as a new threat to global economic growth. The bond bid extended on Monday, with 10-year U.S. yields sliding as low as 1.62%, the lowest since October.That latest leg down came after JPMorgan strategists had calculated that yields were almost 30 basis points “too low” compared with expectations for growth, inflation and Federal Reserve policy decisions, along with gauges of investor positioning and the share of negative-yielding debt in developed markets.“Ten-year Treasuries have not been this dislocated on this basis since a brief period in the spring of 2015,” JPMorgan calculated. “We remain short 30-year U.S. Treasuries.”‘Buying Opportunities’Turning to stocks, JPMorgan’s equity strategists flagged that the health-scare could lead to more near-term declines, while concluding that “past pandemics episodes didn’t lead to sustained selling, they tended to ultimately be buying opportunities.”On the currency side, JPMorgan shifted its emerging Asia position to neutral, thanks to closing its overweight recommendation on Malaysia’s ringgit, which on Friday snapped a four-week winning streak.“Such outbreaks can subside as quickly as they have emerged,” JPMorgan currency strategists led by Paul Meggyesi wrote. “However, previous episodes show that risk appetite can be disrupted for at least a number of weeks, particularly from an FX standpoint.”(Adds comments on stocks and currencies starting in second paragraph.)To contact the reporter on this story: Christopher Anstey in Tokyo at canstey@bloomberg.netTo contact the editors responsible for this story: Chris Nagi at chrisnagi@bloomberg.net, Cormac Mullen, Ravil ShirodkarFor more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.


  • Don't Sell China East Education Holdings Limited (HKG:667) Before You Read This

    The goal of this article is to teach you how to use price to earnings ratios (P/E ratios). To keep it practical, we'll...


  • Those Who Purchased Endomines (STO:ENDO) Shares Five Years Ago Have A 88% Loss To Show For It

    Endomines AB (publ) (STO:ENDO) shareholders should be happy to see the share price up 16% in the last month. But that...


  • Arix Co-founds Quench Bio With Series A Financing

    Arix Bioscience plc ("Arix", LSE: ARIX) a global venture capital company focused on investing in and building breakthrough biotech companies, today announces that its discovery portfolio company Quench Bio has emerged from stealth mode with the completion of a Series A financing. This follows a period of company creation, with seed investment and close involvement by Arix.


  • Finastra Strengthens Its Position in Israel With New Office Opening

    Finastra is investing further in Israel with a new office in Kfar Saba, just outside Tel Aviv. The office, which is home to over 330 employees, offers more space for the Finastra team to grow as the company strengthens its position in the country, and provides an ultra-modern workspace to inspire creativity and facilitate collaboration. The move will help the company support technological and financial innovation in the region, and drive adoption of its open development platform, FusionFabric.cloud.


  • Reiss Holdings Limited reports strong like-for-like sales over the Christmas period and continues to expand its global footprint

    Reiss Holdings Limited, the premium international fashion brand, today reported Christmas trading figures for 7 weeks to 18th January 2020.


  • Quench Bio Closes $50M Series A Financing to Advance First-in-Class Medicines Targeting Gasdermin to Treat Severe Inflammatory Diseases

    Quench Bio, a company leveraging new insights into gasdermin biology and innate immunology to develop medicines for severe inflammatory diseases, today announced the completion of a $50 million Series A financing led by RA Capital Management ("RA Capital"), with participation from new Investor Abbvie Ventures. Atlas Venture ("Atlas") and Arix Bioscience plc ("Arix", LSE: ARIX) who co-founded and seeded the company, also participated in the Series A. Quench Bio has incubated at Atlas since inception.


  • Crowe Global Reports Eight Years of Consecutive Growth

    Crowe Global (Crowe) reports an outstanding eight years of consecutive growth. The eighth largest audit, tax and advisory network in the world announced global revenues of US$4.4.bn in 2019, an increase of 3.5% (excluding Forex impact).


  • Industry Leaders Back new Specialist led Investment Company for Technology Start-ups

    Bloc Ventures Limited (Bloc), the venture capital company focussed on early stage European deep technology investment, today announces it has raised over £20m in equity funding from UK industry leaders.


(ARA) - The presents have been opened and the gift wrap has been thrown away, and the holiday shopping season has come to a close. A time-honored tradition to be sure, but also one that was hopefully approached thoughtfully. As virtually anyone can tell you, it's easy to spend, but once you've spent too much, you might find yourself in a financial challenge.

For many shoppers, a shopping decision is as easy as pulling out a credit card. And although cards can be a good way to build credit and earn rewards, when used wisely, they can also be a downfall for some shoppers who use them carelessly. According to a recent Consumer Reports survey, as many as 14 million people admitted that they're still paying off purchases from last year's holiday season.

"If it's taking more than a year to pay off purchases, you're possibly on the way to damaged credit," says Barrett Burns, CEO of VantageScore Solutions, LLC. "The short term enjoyment that you might get from a purchase could be far outweighed by potential stress that could come later when those credit card bills come due. Taking steps to maintain good credit will alleviate a lot of headaches and allow you to take advantage of record low interest rates."

If you make smart shopping decisions throughout the year, you'll be protecting yourself from financial stress down the road. But it's also important to remember that even if you've already overspent, you can still make wise decisions about your credit going forward that can help you in the long term. Keep these credit score tips from VantageScore Solutions in mind.

When shopping
* Apply for credit sparingly. Although there are plenty of tempting offers and advertisements for credit cards, every new credit card account will appear on your credit report. Too many new credit card accounts over a short period of time can potentially damage your credit score. While the temptation might be there, you should apply for credit with the same thoughtfulness you'd use when making purchases with a credit card.

* Plan ahead. Credit scores take into account how much available credit you have. If you are planning on making a large purchase on credit in the future, consider limiting the use of your credit cards. This will not only allow you to retain your available credit balance, but can help you in getting the best interest rate for that big purchase.

If you've overspent
* Reduce your balance. A lower balance can help to improve your score and leave room for unexpected expenditures. A good rule of thumb is to try to keep balances under 30 percent of your total credit limit. For example, if your credit card limit is $3,000, try to keep your balance under $900. Although it is important to pay your all of your credit obligations, try to put more effort into bringing down higher balances to under the 30 percent threshold.

* Make payments on time. Establishing a positive payment history by paying your credit obligations on time, each and every month, can have one of the biggest impacts on your credit score. Don't let one missed or late payment potentially damage the credit score that you have worked hard all year to maintain. In addition, by maintaining a good credit score, you can help ensure that you get the most favorable interest rates on your credit accounts.

Taking a thoughtful approach to shopping - and paying off your shopping bills - can help you not only make smart purchases, but keep your credit score in good shape for the future. To learn more, go to www.vantagescore.com and visit www.creditscorequiz.org to test your knowledge about credit scoring.Smart shopping tips to keep your credit healthy
Category: Business